BRIEF-Inovio initiates Phase 2 efficacy trial with VGX-3100 for HPV-related vulvar pre-cancers
April 24 Inovio Pharmaceuticals Inc:
* Inovio initiates phase 2 efficacy trial with VGX-3100 for HPV-related vulvar pre-cancers
* Plans to initiate a phase 3 study of VGX-3100 as a treatment for high grade cervical dysplasia in 2017 Source text for Eikon: Further company coverage:
Gunman in California UPS shooting targeted co-workers for slayings
June 23 The UPS employee who shot three coworkers to death last week inside a United Parcel Service facility in San Francisco before killing himself appears to have singled out his victims deliberately, but a motive remains unknown, police said on Friday.